DBX Demineralized Bone Matrix Putty 10cc-Indicated for treatment of surgically created osseous de...
FDA Device Recall #Z-0323-2024 — Class II — September 22, 2023
Recall Summary
| Recall Number | Z-0323-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 22, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Musculoskeletal Transplant Foundation, Inc. |
| Location | Edison, NJ |
| Product Type | Devices |
| Quantity | 18 units |
Product Description
DBX Demineralized Bone Matrix Putty 10cc-Indicated for treatment of surgically created osseous defects or osseous defects created from traumatic injury. Model Number: 038100
Reason for Recall
Units are labeled as 10cc; however the units have a fill volume of 1cc units. This may result in prolongation of surgery.
Distribution Pattern
US Nationwide distribution in the states of PA, TX, WA.
Lot / Code Information
GUID: W4184038100T0473 Serial #s: 002220854711400006 002220854711400056 002220854711400003 002220854711400008 002220854711400009 002220854711400001 002220854711400002 002220854711400010 002220854711400011 002220854711400012 002220854711400013 002220854711400014 002220854711400004 002220854711400005 002220854711400007 Exp.Date: June 20, 2025
Other Recalls from Musculoskeletal Transplant Foundation...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1066-2024 | Class II | AFT (Allograft Filler Tube) Straight Tube (1/2 ... | Dec 22, 2023 |
| Z-1067-2024 | Class II | AFT (Allograft Filler Tube) Diverted Tube (3/4 ... | Dec 22, 2023 |
| Z-1562-2021 | Class II | AFT Straight Tube (3/4 Filled) - Human Allograp... | Mar 29, 2021 |
| Z-2548-2019 | Class II | QuickGraft¿ Model # 430PST | Aug 15, 2019 |
| Z-2004-2016 | Class II | Musculoskeletal Transplant Foundation, AFT Dive... | Apr 21, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.